In a significant advancement in the field of allergy care, The Food Allergy Immunotherapy Centre is proud to announce its rebranding to the "Allergy Centre of Excellence".
—
In a significant advancement in the field of allergy care, The Food Allergy Immunotherapy Centre is proud to announce its rebranding to the "Allergy Centre of Excellence". This transformation underscores our continued commitment to pioneering developments in managing and treating food allergies.
Enhanced Commitment to Clinical Excellence and Patient-Centered Care
The Allergy Centre of Excellence, previously known as The Food Allergy Immunotherapy Centre, has deepened its commitment to clinical excellence and patient-centred care, evidenced by its robust expansion in service offerings and its dedication to safety and effectiveness in treatment protocols. Founded by the renowned Professors Gideon Lack, Adam Fox, and George du Toit, the centre continues to lead in pediatric allergy care. It advances its mission through innovative treatments like PALFORZIA. This FDA-approved therapy for peanut allergies exemplifies the centre's pivotal role in transforming allergy treatment from avoidance to active management.
The rebranding to the Allergy Centre of Excellence symbolises a broader mission to encompass comprehensive allergy care, ensuring top-tier safety standards and a responsive, patient-first approach that aligns with the complex needs of families and individuals facing challenging allergy conditions.
Revolutionising Allergy Treatment with PALFORZIA
Marking a significant milestone, the licensing of PALFORZIA in 2020 catalysed the rebranding. PALFORZIA, the first licensed food immunotherapy treatment in the US and Europe, represents a paradigm shift—from merely avoiding allergens to actively protecting against them. This treatment and others developed from extensive international studies are now more accessible through our collaboration with Great Ormond Street Hospital, equipped with state-of-the-art facilities for safe allergen administration.
Expanding Services to Meet Growing Needs
In response to the rising prevalence of severe food allergies, the Allergy Centre of Excellence has significantly expanded its desensitisation treatments beyond the PALFORZIA program to include cashew, sesame, and walnuts. These additions leverage recent advances in oral immunotherapy (OIT) that demonstrate effective desensitisation, offering substantial improvements in safety and quality of life for allergy sufferers.
The cashew OIT, for example, has shown promising results, with the majority of treated patients able to tolerate substantial amounts of cashew protein, which also extends cross-tolerance to related nuts like pistachio. Similar protocols are applied to sesame and walnuts, addressing the urgent need for effective treatments in these areas and providing comprehensive care under the rigorous safety protocols of the Centre. This strategic expansion directly responds to patient needs and reflects the Centre's commitment to incorporating cutting-edge research into practical, life-enhancing treatments for food allergies.
A Process Driven by Integrity and Empathy
The process of allergy desensitisation at our centre remains thorough and patient-focused. We emphasise shared decision-making, ensuring families receive comprehensive information to make informed choices about their treatment options. Our procedures are meticulously designed to provide safety and efficacy, with a clear pathway from assessment to maintenance phases of treatment.
Looking Forward: A Future of Innovation and Care
As the Allergy Centre of Excellence, we are excited to pave the way for future innovations in allergy treatment. Our mission is deeply rooted in empathy, clinical excellence, integrity, respect, and teamwork. We are dedicated to advancing the field of allergy care, driven by a commitment to improving the lives of our patients and setting new standards in healthcare.
Contact Info:
Name: The Allergy Centre of Excellence
Email: Send Email
Organization: The Allergy Centre of Excellence
Website: https://allergycentre.co.uk/
Release ID: 89128158
Should any problems, inaccuracies, or doubts arise from the content contained within this press release, we kindly request that you inform us immediately by contacting error@releasecontact.com. Our dedicated team will promptly address your concerns within 8 hours, taking necessary steps to rectify identified issues or assist with the removal process. Providing accurate and dependable information is at the core of our commitment to our readers.
